Cite
HARVARD Citation
Fischer, J. et al. (n.d.). In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations. European journal of cancer. pp. S81-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fischer, J. et al. (n.d.). In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations. European journal of cancer. pp. S81-. [Online].